Login / Signup

Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis.

Asger Sand Paludan-MüllerAndreas LundhMatthew J PageKlaus Munkholm
Published in: PloS one (2021)
CRD42021255915.
Keyphrases
  • coronavirus disease
  • sars cov
  • randomized controlled trial